Important Note Regarding Zykadia Patient Information Leaflets

Zykadia packs containing the now superseded Patient Information Leaflet may continue to be dispensed to patients. These packs contain a leaflet advising patients of the fasted dosing regimen and the starting dose of 750 mg. Please alert patients starting on, or transitioning, to the new 450 mg fed dosing regimen of this fact.

Zykadia®▼ (ceritinib) 150 mg Capsules replaced by Zykadia 150 mg film coated Tablets

Please note Zykadia®▼ (ceritinib) 150 mg Capsules are no longer available to order and have been replaced by Zykadia 150 mg film coated Tablets. The Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) for Zykadia Capsules remains available for those currently using any remaining stock of the capsules. If you require any further information, please do not hesitate to contact the Medical Information Department on 01276 698370.